HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
M Dayan Selected Research
M Dayan Research Topics
Disease
7
Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2005 - 03/2000
2
Stroke (Strokes)
02/2013 - 11/2011
2
Autoimmune Diseases (Autoimmune Disease)
02/2002 - 01/2001
2
Leukopenia
01/2001 - 01/2001
2
Proteinuria
01/2001 - 01/2001
1
Atrophy
04/2015
1
Myasthenia Gravis
08/2005
1
Nervous System Diseases (Neurological Disorders)
08/2005
1
Raynaud Disease (Raynaud's Disease)
02/2002
1
Pneumonia (Pneumonitis)
02/2002
1
Exanthema (Rash)
02/2002
1
Ulcer
02/2002
1
Inflammation (Inflammations)
10/2000
1
Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis)
02/2000
Drug/Important Bio-Agent (IBA)
4
Peptides (Polypeptides)
IBA
08/2005 - 04/2000
3
Autoantibodies
IBA
08/2005 - 02/2002
3
DNA (Deoxyribonucleic Acid)
IBA
02/2003 - 04/2000
2
Leptin
IBA
02/2013 - 11/2011
2
Antibodies
IBA
08/2005 - 02/2002
2
Antigen-Antibody Complex (Immune Complex)
IBA
01/2001 - 01/2001
2
Monoclonal Antibodies
IBA
01/2001 - 04/2000
1
Biomarkers (Surrogate Marker)
IBA
04/2015
1
Adenylate Kinase
IBA
02/2013
1
Dihydrotachysterol (AT 10)
IBA
02/2013
1
Leptin Receptors
IBA
11/2011
1
Uridine
IBA
11/2011
1
N-Methyl-D-Aspartate Receptors (NMDA Receptors)
IBA
08/2005
1
N-Methylaspartate (NMDA)
IBA
08/2005
1
Epitopes
IBA
08/2005
1
Glutamic Acid (Glutamate)
FDA Link
08/2005
1
Complementarity Determining Regions (Complementarity Determining Region)
IBA
02/2003
1
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
02/2002
1
Phospholipids (Phosphatides)
FDA Link
Generic
02/2002
1
Solutions
IBA
01/2001
1
Interleukin-1 (Interleukin 1)
IBA
01/2001
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2001
1
Retinaldehyde (Retinal)
IBA
10/2000
1
Autoantigens
IBA
10/2000
1
Antigens
IBA
10/2000
1
Cardiolipins (Cardiolipin)
IBA
04/2000
1
Cytokines
IBA
03/2000
1
T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
IBA
02/2000
Therapy/Procedure
1
Treatment Delay
02/2013
1
Injections
01/2001
1
Oral Administration
02/2000